Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000415852 | SCV000493301 | benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | ZNF469: BP4, BS1, BS2 |
Gene |
RCV000428615 | SCV000528870 | benign | not specified | 2017-12-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000428615 | SCV000703607 | likely benign | not specified | 2016-12-16 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000415852 | SCV001723657 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002278650 | SCV002565229 | benign | Ehlers-Danlos syndrome | 2022-04-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002379280 | SCV002694764 | benign | Cardiovascular phenotype | 2019-01-09 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002502447 | SCV002795986 | benign | Brittle cornea syndrome 1 | 2021-07-15 | criteria provided, single submitter | clinical testing |